Coming Soon
Find comprehensive information on Laryngeal Cancer (C71), also known as Throat Cancer and Cancer of Larynx. This resource provides healthcare professionals with key details for accurate clinical documentation and medical coding related to C71, including symptoms, diagnosis, treatment, and prognosis. Learn about ICD-10 code C71 and explore relevant medical terminology for optimized healthcare information retrieval.
Also known as
Malignant neoplasm of larynx
Cancer originating in the larynx, including glottis, supraglottis, and subglottis.
Malignant neoplasm of thyroid gland
Cancer originating in the thyroid gland, sometimes considered related to throat cancer.
Malignant neoplasm of oropharynx
Cancer of the oropharynx, part of the throat, sometimes grouped with laryngeal cancers.
Malignant neoplasms
Broad category encompassing all malignant neoplasms, including laryngeal cancer.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the larynx the primary site?
When to use each related code
| Description |
|---|
| Cancer of the larynx |
| Laryngeal papilloma |
| Laryngitis |
Missing or incorrect laterality (right, left, bilateral) can impact staging and reimbursement.
Documentation must specify the subsites within the larynx (glottis, supraglottis, subglottis) for accurate coding.
Coding requires histological confirmation of malignancy. Clinical diagnosis alone is insufficient for C71.x codes.
Q: What are the most effective current staging guidelines for laryngeal cancer to ensure accurate prognosis and treatment planning for my patients?
A: Accurate staging is crucial for laryngeal cancer management. The current gold standard is the 8th edition of the American Joint Committee on Cancer (AJCC) TNM staging system, which incorporates tumor size (T), lymph node involvement (N), and distant metastasis (M). This system provides a detailed classification allowing for personalized treatment strategies and prognostication. Beyond the AJCC, clinicians should consider incorporating imaging findings from CT and MRI scans, and in specific cases, PET scans, for more precise T and N staging. Explore how integrating these imaging modalities can refine your laryngeal cancer staging process and lead to improved patient outcomes. Consider implementing a multidisciplinary tumor board review to discuss complex cases and ensure consensus on staging and treatment.
Q: How do I differentiate between early-stage laryngeal cancer symptoms and more common benign conditions like laryngitis or vocal cord nodules in a patient presenting with hoarseness?
A: Differentiating laryngeal cancer from benign conditions like laryngitis or vocal cord nodules can be challenging, especially in early stages where hoarseness is a common symptom. Persistent hoarseness lasting longer than two weeks warrants further investigation. While laryngitis often resolves within this timeframe, laryngeal cancer symptoms tend to persist and may be accompanied by other signs like dysphagia, odynophagia, hemoptysis, referred otalgia, or a neck mass. A thorough clinical examination, including fiberoptic laryngoscopy, is essential for visualization of the larynx. If any suspicion remains, a biopsy is mandatory for definitive diagnosis. Learn more about the subtle clinical clues that can help distinguish laryngeal cancer from benign laryngeal conditions and consider implementing standardized diagnostic pathways in your practice to ensure timely cancer detection.
Patient presents with complaints consistent with possible laryngeal cancer, including persistent hoarseness, dysphagia, odynophagia, and a neck mass. The patient reports a history of heavy tobacco use and moderate alcohol consumption, significant risk factors for laryngeal carcinoma. Physical examination revealed palpable cervical lymphadenopathy. Flexible laryngoscopy demonstrated a suspicious lesion on the right vocal cord. Differential diagnosis includes vocal cord nodules, polyps, laryngitis, and reflux laryngitis. Given the patient's history, symptoms, and examination findings, laryngeal cancer is a primary concern. Biopsy is scheduled to confirm the diagnosis and determine the histological type and staging of the potential throat cancer. Preliminary diagnostic impressions include squamous cell carcinoma of the larynx, pending histopathological confirmation. Treatment options, including surgery, radiation therapy, chemotherapy, and targeted therapy will be discussed upon receipt of pathology results. ICD-10 code C32.9 (Malignant neoplasm of larynx, unspecified) is provisionally assigned, subject to change based on biopsy findings. CPT codes for the laryngoscopy and biopsy will be documented upon procedure completion. Patient education provided regarding laryngeal cancer symptoms, diagnosis, treatment pathways, and potential side effects. Referral to oncology and speech therapy will be made upon confirmation of malignancy. The patient understands the importance of follow-up care and agrees to adhere to the recommended treatment plan.